Alkermes Inc. plc

ALKS XNAS PHARMACEUTICAL PREPARATIONS

Market Cap

6.9B

Short interest (May 15)

11.0%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.41%

↑ 46.3%

Available Shares

1M

↓ 38.2%

Price Chart

Company Overview

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Company Info

Exchange: NASDAQ
Industry: PHARMACEUTICAL PREPARATIONS
CIK: 0001520262
Asset Type: CS

Market Data

Market Cap: $6,887,044,345
Employees: 2,050
Status: Active

Short Interest

Current Borrow Fee 0.41%
Range: 0.41% - 0.41%
Available Shares 1M
Range: 1M - 1.1M

Recent Changes

Fee Change: ↑ 1.3%
Available Change: ↓ 11.4%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime